Stockreport

Abbott gets FDA nod to begin IVL trial after rivals buy up competition [Yahoo! Finance]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF Abbott said Monday it has received approval to start a U.S. clinical trial of a treatment for severe calcification in coronary arteries. The intravascular lithotripsy [Read more]